Related Experiment Videos
[Semen analysis under photochemotherapy (PUVA-therapy) (author's transl)]
Archives of Dermatological Research
|March 31, 1979
Summary
Photochemotherapy with 8-methoxypsoralen and UVA (PUVA) did not impair male fertility in psoriasis patients. Semen quality remained stable, with only a slight decrease in ejaculate volume observed during treatment.
Area of Science:
- Dermatology
- Reproductive Medicine
- Photobiology
Context:
- Psoriasis vulgaris is a chronic skin condition often treated with photochemotherapy.
- Concerns exist regarding the potential impact of 8-methoxypsoralen and UVA (PUVA) therapy on male reproductive health.
- Assessing fertility in men undergoing PUVA treatment is crucial for reproductive-aged patients.
Purpose:
- To evaluate the effects of PUVA therapy on semen parameters in male patients with psoriasis vulgaris.
- To determine if PUVA treatment causes toxic damage to spermatogenesis or impairs fertility.
- To investigate potential fertility impairment due to scrotal hyperthermia during PUVA therapy.
Summary:
- A pilot study analyzed semen parameters in 9 male psoriasis patients before and during PUVA therapy.
- Key parameters including sperm motility, density, morphology, and seminal plasma fructose remained unchanged.
- A minor reduction in ejaculate volume was the only observed change during the 3-month treatment period.
Impact:
- This study provides evidence that PUVA therapy is unlikely to impair fertility in men of reproductive age.
- Findings suggest that male patients with psoriasis can undergo PUVA treatment without significant reproductive concerns.
- The research contributes to understanding the safety profile of photochemotherapy for male fertility.